Cargando…

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status

BACKGROUND: The phase III REMoxTB study prospectively enrolled HIV-positive (with CD4+ count > 250 cells, not on anti-retroviral therapy) and HIV-negative patients. We investigated the incidence of adverse events and cure rates according to HIV status for patients receiving standard TB therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tweed, Conor D., Crook, Angela M., Dawson, Rodney, Diacon, Andreas H., McHugh, Timothy D., Mendel, Carl M., Meredith, Sarah K., Mohapi, Lerato, Murphy, Michael E., Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha P., Spigelman, Melvin, Gillespie, Stephen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694514/ https://www.ncbi.nlm.nih.gov/pubmed/31412895 http://dx.doi.org/10.1186/s12890-019-0907-6

Ejemplares similares

Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
por: Tweed, Conor Duncan, et al.
Publicado: (2018)

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study
por: Tweed, Conor D., et al.
Publicado: (2018)

Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study
por: Murphy, M. E., et al.
Publicado: (2018)

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens
por: Phillips, Patrick P. J., et al.
Publicado: (2017)

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
por: Tweed, C. D., et al.
Publicado: (2021)

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
por: Oelofse, S., et al.
Publicado: (2021)

Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

Clofazimine pharmacokinetics in patients with TB: dosing implications
por: Abdelwahab, Mahmoud Tareq, et al.
Publicado: (2020)

Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis
por: Murthy, S. E., et al.
Publicado: (2018)

TB Anywhere is TB Everywhere
por: Wortham, Jonathan M.
Publicado: (2018)

TB or not TB! That’s the question
por: Nugud, Ahmed, et al.
Publicado: (2019)

Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
por: Tweed, Conor D, et al.
Publicado: (2019)

Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial
por: Chen, Ray Y., et al.
Publicado: (2017)

Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease
por: Mbelele, P. M., et al.
Publicado: (2022)

Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial
por: Phillips, P. P. J., et al.
Publicado: (2020)

Striking the Right Balance Determines TB or Not TB
por: BoseDasgupta, Somdeb, et al.
Publicado: (2014)

Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age
por: Bae, Won, et al.
Publicado: (2016)

Inequality in the global incidence and prevalence of tuberculosis (TB) and TB/HIV according to the human development index
por: Okhovat-Isfahani, Batoul, et al.
Publicado: (2019)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

Atripla(R)/anti-TB combination in TB/HIV patients. Drug in focus
por: Semvua, Hadija H, et al.
Publicado: (2011)

The Q-value of $^{157}$Tb
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1983)

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting
por: Cates, L., et al.
Publicado: (2021)

XDR-TB in South Africa: Back to TB Sanatoria Perhaps?
por: Sakoane, Ramalitse
Publicado: (2007)

High prevalence of TB disease in contacts of adults with extrapulmonary TB
por: Wingfield, Tom, et al.
Publicado: (2018)

Assessing the impact of TB/HIV services integration on TB treatment outcomes and their relevance in TB/HIV monitoring in Ghana
por: Ansa, Gloria Akosua, et al.
Publicado: (2012)

Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries
por: Jarde, Alexander, et al.
Publicado: (2022)

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis
por: Murphy, Michael E., et al.
Publicado: (2017)

Combination of Cytokine Responses Indicative of Latent TB and Active TB in Malawian Adults
por: Hur, Yun-Gyoung, et al.
Publicado: (2013)

Finding gaps in TB notifications: spatial analysis of geographical patterns of TB notifications, associations with TB program efforts and social determinants of TB risk in Bangladesh, Nepal and Pakistan
por: van Gurp, Margo, et al.
Publicado: (2020)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Framework of behavioral indicators for outcome evaluation of TB health promotion: a Delphi study of TB suspects and Tb patients
por: Li, Ying, et al.
Publicado: (2014)

Is intermittent short-course anti-TB regimen as efficient and safe as daily anti-TB regimen for treating childhood TB?
por: Bhaumik, Soumyadeep
Publicado: (2015)

SEVERITY OF TB CLASSIFIED BY MODIFIED BANDIM TB SCORING ASSOCIATES WITH THE SPECIFIC SEQUENCE OF ESXA GENES IN MDR-TB PATIENTS
por: Dewi, Desak Nyoman Surya Suameitria, et al.
Publicado: (2020)

Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection
por: Humayun, Maheen, et al.
Publicado: (2022)

Correction: Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries
por: Jarde, Alexander, et al.
Publicado: (2023)

Advances in clinical trial design: Weaving tomorrow’s TB treatments
por: Lienhardt, Christian, et al.
Publicado: (2020)

Cost of TB services: approach and summary findings of a multi-country study (Value TB)
por: Sweeney, S., et al.
Publicado: (2022)

Confronting TB/HIV in the era of increasing anti-TB drug resistance
por: Chakaya, Jeremiah, et al.
Publicado: (2008)

TB or not TB? Difficulties in the diagnosis of tuberculosis in HIV-negative immigrants to Germany
por: Singh, DD, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6usk593r79mma3agdap8iq1rvr